A modified human repeat insult patch test for extended mucosal tissue exposure

Contact Dermatitis

Volumn 49, Issue 4, 2003, Pages 214-215

  Farage, Miranda A ^a   Bjerke, Donald L ^b   Mahony, Catherine ^c   Blackburn, Karen L ^b   Gerberick, G Frank ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b Central Product Safety   (United States)

^c Winston Hill Business Center ^*

Author keywords

Extended exposure; Human repeat insult patch test; Mucosa; Risk assessment

Indexed keywords

ARTICLE; CONTACT SENSITIZATION; DIAGNOSTIC PROCEDURE; EXPOSURE; HUMAN; MOUTH MUCOSA; MUCOSA; PATCH TEST; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VAGINA MUCOSA;

EID: 1242337419     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-1873.2003.0206c.x     Document Type: Article

References (6)

1. Lesch C A, Squier C A, Cruchley A, Williams D M, Speight P. The permeability of human oral mucosa and skin to water. J Dent Res 1989: 68: 1345-1349.
2. Gerberick G F, Sikorski E E. In vitro and in vivo testing techniques for allergic contact dermatitis. Am J Contact Dermat 1998: 9: 111-118.
3. Kligman A M. The identification of contact allergens by human assay. II. Factors influencing the induction and measurement of allergic contact dermatitis. J Invest Dermatol 1966: 47: 375-392.
4. Jordan W P Jr, King S E. Delayed hypersensitivity in females. The development of allergic contact dermatitis in females during the comparison of two predictive patch tests. Contact Dermatitis 1977: 3: 19-26.
5. Jordan W P. 24-, 48-, and 48/48-hour patch tests. Contact Dermatitis 1980: 6: 151-152.
6. U.S. Department of Health and Human Services. Food and Drug. Administration Center for Drug Evaluation and Research. December 1999. Guidance for Industry: Skin Irritation and Sensitization Testing of Generic Transdermal Drug Products, December 1999. (Available from: http://www.fda. gov/cder/guidance/2887fnl.htm)